Edition:
United States

ICON PLC (ICLR.OQ)

ICLR.OQ on NASDAQ Stock Exchange Global Select Market

125.74USD
18 May 2018
Change (% chg)

$2.48 (+2.01%)
Prev Close
$123.26
Open
$123.33
Day's High
$125.78
Day's Low
$121.71
Volume
47,379
Avg. Vol
102,658
52-wk High
$126.65
52-wk Low
$86.23

Chart for

About

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the... (more)

Overall

Beta: 0.55
Market Cap(Mil.): $6,140.73
Shares Outstanding(Mil.): 54.04
Dividend: --
Yield (%): --

Financials

  ICLR.OQ Industry Sector
P/E (TTM): 23.06 84.06 32.75
EPS (TTM): 4.93 -- --
ROI: 20.24 1.57 14.38
ROE: 28.29 2.43 16.07

BRIEF-Icon To Cut Administrative Costs And Raise Regulatory Compliance

* ICON LAUNCHES FIRECREST FINANCIAL DISCLOSURE TO REDUCE ADMINISTRATIVE COSTS AND INCREASE REGULATORY COMPLIANCE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

May 21 2018

BRIEF-ICON Plc Reports Q1 Earnings Per Share Of $1.42

* EXCLUDING IMPACT OF ASC 606, CLOSING BACKLOG OF $5,053 MILLION AT QUARTER END , AN INCREASE OF 17.2% YEAR ON YEAR

May 02 2018

BRIEF-ICON Announces Deal With Intel Allowing Integration Of The Intel Pharma Analytics Platform For Clinical Trials

* ICON ANNOUNCES AGREEMENT WITH INTEL ALLOWING INTEGRATION OF THE INTEL® PHARMA ANALYTICS PLATFORM FOR CLINICAL TRIALS

Apr 17 2018

BRIEF-Icon PLC Reports Qtrly EPS Of $1.43​

* ‍IN Q4 NET REVENUE GREW 4.6% YEAR ON YEAR TO $455 MILLION FROM $435 MILLION IN SAME QUARTER LAST YEAR​

Feb 15 2018

BRIEF-Icon Expects FY2018 Revenue In Range Of $1,870 Mln - $1,930 Mln

* - ‍FULL YEAR 2018 REVENUE GUIDANCE IN RANGE OF $1,870 - $1,930 MILLION, REPRESENTING GROWTH OF 7 - 10%​

Jan 09 2018

Earnings vs. Estimates